Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Kuang-Kai Liu"'
Autor:
Yu-Wei Lin, Hung-Cheng Su, Emmanuel Naveen Raj, Kuang-Kai Liu, Chien-Jen Chang, Tzu-Chia Hsu, Po-Yun Cheng, Rou-Hsin Wang, Yen-Her Lai, Chien-Hung Chen, Yen-Cheng Lin, Jui-I Chao
Publikováno v:
Pharmaceutics, Vol 15, Iss 1, p 111 (2022)
Nanoprobes provide advantages for real-time monitoring of tumor markers and tumorigenesis during cancer progression and development. Epidermal growth factor receptor (EGFR) is a key protein that plays crucial roles for tumorigenesis and cancer therap
Externí odkaz:
https://doaj.org/article/174683a338e84a5788c13d3eecfa23ae
Publikováno v:
Anti-Cancer Agents in Medicinal Chemistry. 23:1309-1319
Background: Lung cancer has become one of the leading causes of cancer incidence and mortality worldwide. Non-small cell lung carcinoma (NSCLC) is the most common type among all lung cancer cases. NSCLC patients contained high levels of activating ep
Autor:
Kun Ping Lu, Wei Siang Liao, Xiao Zhen Zhou, Yu Wei Lin, Chinpiao Chen, Jui-I Chao, Emmanuel Naveen Raj, Kuang Kai Liu, Yu Ho
Publikováno v:
Acta Biomaterialia. 86:395-405
Breast cancer is the most common malignancy and a leading cause of cancer-related mortality among women worldwide. Triple-negative breast cancer (TNBC) is characterized by the lack of estrogen receptor (ER), progesterone receptor (PR) and human epide
Autor:
Yu-Chi Chan, Mei-Chih Liang, Chinpiao Chen, Chien-Jen Chang, Ya-Hui Wu, Pei-Ying Pan, Rou-Hsin Wang, Chih-Man Yang, Jinn-Moon Yang, Ya-Ping Hsu, Kuang-Kai Liu, Chien-Hung Chen, Su-Pei Wang, Kwok-Kin Wong, Jui-I Chao
Publikováno v:
Biochemical Pharmacology. 193:114792
Tyrosine kinase inhibitors of epidermal growth factor receptor (EGFR-TKIs) are currently used therapy for non-small cell lung cancer (NSCLC) patients; however, drug resistance during cancer treatment is a critical problem. Survivin is an anti-apoptos
Autor:
Jui-I Chao, Lily Yi Li, Ting Hua Chen, Hsiao Chun Cheng, Kuang Kai Liu, Emmanuel Naveen Raj, Johnson Lin, Yu Wei Lin, Chinpiao Chen, Wei Siang Liao, Chi Ching Wang
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Scientific Reports
Scientific Reports
The poor intracellular uptake and non-specific binding of anticancer drugs into cancer cells are the bottlenecks in cancer therapy. Nanocarrier platforms provide the opportunities to improve the drug efficacy. Here we show a carbon-based nanomaterial
Publikováno v:
Advanced Therapeutics. 3:2000085
Autor:
Tzu-Chia Hsu1, Kuang-Kai Liu2, Huan-Cheng Chang3, Eric Hwang1,2,4, Jui-I Chao1,2 jichao@faculty.nctu.edu.tw
Publikováno v:
Scientific Reports. 5/16/2014, p1-11. 11p.
Publikováno v:
Biomaterials. 30:4249-4259
Nanodiamond (ND) is carbon nanomaterial developing for biological applications in recent years. In this study, we investigated the location and distribution of 100 nm carboxylated ND particles in cell division and differentiation. ND particles were t
Autor:
Kuang Kai Liu, P. H. Chung, Elena Perevedentseva, Chia-Liang Cheng, Chih Yuan Cheng, Jui-I Chao, Chia-Ching Chang
Publikováno v:
Biophysical Journal. 93:2199-2208
A novel method is proposed using nanometer-sized diamond particles as detection probes for biolabeling. The advantages of nanodiamond's unique properties were demonstrated in its biocompatibility, nontoxicity, easily detected Raman signal, and intrin
Autor:
Hou Syun Huang, Jui-I Chao, Chun Wei Kao, Tzai-Wen Chiu, Kuang Kai Liu, Eric Hwang, Ming Han Chiang, Ching Ren Soo, Huan-Cheng Chang, Yung An Huang
Publikováno v:
Scientific Reports
Nanodiamond (ND) has emerged as a promising carbon nanomaterial for therapeutic applications. In previous studies, ND has been reported to have outstanding biocompatibility and high uptake rate in various cell types. ND containing nitrogen-vacancy ce